Illinois 2025-2026 Regular Session

Illinois Senate Bill SB0009 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB0009 Introduced 1/13/2025, by Sen. Linda Holmes SYNOPSIS AS INTRODUCED: New Act Creates the End-of-Life Options for Terminally Ill Patients Act. Authorizes a qualified patient with a terminal disease to request that a physician prescribe aid-in-dying medication that will allow the patient to end the patient's life in a peaceful manner. Contains provisions concerning: the procedures and forms to be used to request aid-in-dying medication; the responsibilities of attending and consulting physicians; the referral of patients for determinations of mental capacity; the residency of qualified patients; the safe disposal of unused medications; the obligations of health care entities; the immunities granted for actions taken in good faith reliance upon the Act; the reporting requirements of physicians; the effect of the Act on the construction of wills, contracts, and statutes; the effect of the Act on insurance policies and annuities; the procedures for the completion of death certificates; the liabilities and penalties provided by the Act; the construction of the Act; the definitions of terms used in the Act; and other matters. Effective 6 months after becoming law. LRB104 06297 BDA 16332 b A BILL FOR 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB0009 Introduced 1/13/2025, by Sen. Linda Holmes SYNOPSIS AS INTRODUCED: New Act New Act Creates the End-of-Life Options for Terminally Ill Patients Act. Authorizes a qualified patient with a terminal disease to request that a physician prescribe aid-in-dying medication that will allow the patient to end the patient's life in a peaceful manner. Contains provisions concerning: the procedures and forms to be used to request aid-in-dying medication; the responsibilities of attending and consulting physicians; the referral of patients for determinations of mental capacity; the residency of qualified patients; the safe disposal of unused medications; the obligations of health care entities; the immunities granted for actions taken in good faith reliance upon the Act; the reporting requirements of physicians; the effect of the Act on the construction of wills, contracts, and statutes; the effect of the Act on insurance policies and annuities; the procedures for the completion of death certificates; the liabilities and penalties provided by the Act; the construction of the Act; the definitions of terms used in the Act; and other matters. Effective 6 months after becoming law. LRB104 06297 BDA 16332 b LRB104 06297 BDA 16332 b A BILL FOR
2	2	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB0009 Introduced 1/13/2025, by Sen. Linda Holmes SYNOPSIS AS INTRODUCED:
3	3	New Act New Act
4	4	New Act
5	5	Creates the End-of-Life Options for Terminally Ill Patients Act. Authorizes a qualified patient with a terminal disease to request that a physician prescribe aid-in-dying medication that will allow the patient to end the patient's life in a peaceful manner. Contains provisions concerning: the procedures and forms to be used to request aid-in-dying medication; the responsibilities of attending and consulting physicians; the referral of patients for determinations of mental capacity; the residency of qualified patients; the safe disposal of unused medications; the obligations of health care entities; the immunities granted for actions taken in good faith reliance upon the Act; the reporting requirements of physicians; the effect of the Act on the construction of wills, contracts, and statutes; the effect of the Act on insurance policies and annuities; the procedures for the completion of death certificates; the liabilities and penalties provided by the Act; the construction of the Act; the definitions of terms used in the Act; and other matters. Effective 6 months after becoming law.
6	6	LRB104 06297 BDA 16332 b LRB104 06297 BDA 16332 b
7	7	LRB104 06297 BDA 16332 b
8	8	A BILL FOR
9	9	SB0009LRB104 06297 BDA 16332 b SB0009 LRB104 06297 BDA 16332 b
10	10	SB0009 LRB104 06297 BDA 16332 b
11	11	1 AN ACT concerning health.
12	12	2 Be it enacted by the People of the State of Illinois,
13	13	3 represented in the General Assembly:
14	14	4 Section 1. Short title. This Act may be cited as the
15	15	5 End-of-Life Options for Terminally Ill Patients Act.
16	16	6 Section 5. Definitions. As used in this Act:
17	17	7 "Adult" means an individual 18 years of age or older.
18	18	8 "Advanced practice registered nurse" means an advanced
19	19	9 practice registered nurse licensed under the Nurse Practice
20	20	10 Act who is certified as a psychiatric mental health
21	21	11 practitioner.
22	22	12 "Aid in dying" means an end-of-life care option that
23	23	13 allows a qualified patient to obtain a prescription for
24	24	14 medication pursuant to this Act.
25	25	15 "Attending physician" means the physician who has primary
26	26	16 responsibility for the care of the patient and treatment of
27	27	17 the patient's terminal disease.
28	28	18 "Clinical psychologist" means a psychologist licensed
29	29	19 under the Clinical Psychologist Licensing Act.
30	30	20 "Clinical social worker" means a person licensed under the
31	31	21 Clinical Social Work and Social Work Practice Act.
32	32	22 "Coercion or undue influence" means the willful attempt,
33	33	23 whether by deception, intimidation, or any other means to:
34	34
35	35
36	36
37	37	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB0009 Introduced 1/13/2025, by Sen. Linda Holmes SYNOPSIS AS INTRODUCED:
38	38	New Act New Act
39	39	New Act
40	40	Creates the End-of-Life Options for Terminally Ill Patients Act. Authorizes a qualified patient with a terminal disease to request that a physician prescribe aid-in-dying medication that will allow the patient to end the patient's life in a peaceful manner. Contains provisions concerning: the procedures and forms to be used to request aid-in-dying medication; the responsibilities of attending and consulting physicians; the referral of patients for determinations of mental capacity; the residency of qualified patients; the safe disposal of unused medications; the obligations of health care entities; the immunities granted for actions taken in good faith reliance upon the Act; the reporting requirements of physicians; the effect of the Act on the construction of wills, contracts, and statutes; the effect of the Act on insurance policies and annuities; the procedures for the completion of death certificates; the liabilities and penalties provided by the Act; the construction of the Act; the definitions of terms used in the Act; and other matters. Effective 6 months after becoming law.
41	41	LRB104 06297 BDA 16332 b LRB104 06297 BDA 16332 b
42	42	LRB104 06297 BDA 16332 b
43	43	A BILL FOR
44	44
45	45
46	46
47	47
48	48
49	49	New Act
50	50
51	51
52	52
53	53	LRB104 06297 BDA 16332 b
54	54
55	55
56	56
57	57
58	58
59	59
60	60
61	61
62	62
63	63	SB0009 LRB104 06297 BDA 16332 b
64	64
65	65
66	66	SB0009- 2 -LRB104 06297 BDA 16332 b SB0009 - 2 - LRB104 06297 BDA 16332 b
67	67	SB0009 - 2 - LRB104 06297 BDA 16332 b
68	68	1 (1) cause a patient to request, obtain, or
69	69	2 self-administer medication pursuant to this Act with
70	70	3 intent to cause the death of the patient; or
71	71	4 (2) prevent a qualified patient, in a manner that
72	72	5 conflicts with the Health Care Right of Conscience Act,
73	73	6 from obtaining or self-administering medication pursuant
74	74	7 to this Act.
75	75	8 "Consulting physician" means a physician who is qualified
76	76	9 by specialty or experience to make a professional diagnosis
77	77	10 and prognosis regarding the patient's disease.
78	78	11 "Department" means the Department of Public Health.
79	79	12 "Health care entity" means a hospital or hospital
80	80	13 affiliate, nursing home, hospice or any other facility
81	81	14 licensed under any of the following Acts: the Ambulatory
82	82	15 Surgical Treatment Center Act; the Home Health, Home Services,
83	83	16 and Home Nursing Agency Licensing Act; the Hospice Program
84	84	17 Licensing Act; the Hospital Licensing Act; the Nursing Home
85	85	18 Care Act; or the University of Illinois Hospital Act. "Health
86	86	19 care entity" does not include a physician.
87	87	20 "Health care professional" means a physician, pharmacist,
88	88	21 or licensed mental health professional.
89	89	22 "Informed decision" means a decision by a patient with
90	90	23 mental capacity and a terminal disease to request and obtain a
91	91	24 prescription for medication pursuant to this Act, that the
92	92	25 qualified patient may self-administer to bring about a
93	93	26 peaceful death, after being fully informed by the attending
94	94
95	95
96	96
97	97
98	98
99	99	SB0009 - 2 - LRB104 06297 BDA 16332 b
100	100
101	101
102	102	SB0009- 3 -LRB104 06297 BDA 16332 b SB0009 - 3 - LRB104 06297 BDA 16332 b
103	103	SB0009 - 3 - LRB104 06297 BDA 16332 b
104	104	1 physician and consulting physician of:
105	105	2 (1) the patient's diagnosis and prognosis;
106	106	3 (2) the potential risks and benefits associated with
107	107	4 taking the medication to be prescribed;
108	108	5 (3) the probable result of taking the medication to be
109	109	6 prescribed;
110	110	7 (4) the feasible end-of-life care and treatment
111	111	8 options for the patient's terminal disease, including, but
112	112	9 not limited to, comfort care, palliative care, hospice
113	113	10 care, and pain control, and the risks and benefits of
114	114	11 each;
115	115	12 (5) the patient's right to withdraw a request pursuant
116	116	13 this Act, or consent for any other treatment, at any time;
117	117	14 and
118	118	15 (6) the patient's right to choose not to obtain the
119	119	16 drug or to choose to obtain the drug but not to ingest it.
120	120	17 "Licensed mental health care professional" means a
121	121	18 psychiatrist, clinical psychologist, clinical social worker,
122	122	19 or advanced practice registered nurse.
123	123	20 "Mental capacity" means that, in the opinion of the
124	124	21 attending physician or the consulting physician or, if the
125	125	22 opinion of a licensed mental health care professional is
126	126	23 required under Section 40, the licensed mental health care
127	127	24 professional, the patient requesting medication pursuant to
128	128	25 this Act has the ability to make and communicate an informed
129	129	26 decision.
130	130
131	131
132	132
133	133
134	134
135	135	SB0009 - 3 - LRB104 06297 BDA 16332 b
136	136
137	137
138	138	SB0009- 4 -LRB104 06297 BDA 16332 b SB0009 - 4 - LRB104 06297 BDA 16332 b
139	139	SB0009 - 4 - LRB104 06297 BDA 16332 b
140	140	1 "Oral request" means an affirmative statement that
141	141	2 demonstrates a contemporaneous affirmatively stated desire by
142	142	3 the patient seeking aid in dying.
143	143	4 "Pharmacist" means an individual licensed to engage in the
144	144	5 practice of pharmacy under the Pharmacy Practice Act.
145	145	6 "Physician" means a person licensed to practice medicine
146	146	7 in all of its branches under the Medical Practice Act of 1987.
147	147	8 "Psychiatrist" means a physician who has successfully
148	148	9 completed a residency program in psychiatry accredited by
149	149	10 either the Accreditation Council for Graduate Medical
150	150	11 Education or the American Osteopathic Association.
151	151	12 "Qualified patient" means an adult Illinois resident with
152	152	13 the mental capacity to make medical decisions who has
153	153	14 satisfied the requirements of this Act in order to obtain a
154	154	15 prescription for medication to bring about a peaceful death.
155	155	16 No person will be considered a "qualified patient" under this
156	156	17 Act solely because of advanced age, disability, or a mental
157	157	18 health condition, including depression.
158	158	19 "Self-administer" means an affirmative, conscious,
159	159	20 voluntary action, performed by a qualified patient, to ingest
160	160	21 medication prescribed pursuant to this Act to bring about the
161	161	22 patient's peaceful death. Self-administration does not include
162	162	23 administration by parenteral injection or infusion.
163	163	24 "Terminal disease" means an incurable and irreversible
164	164	25 disease that will, within reasonable medical judgment, result
165	165	26 in death within 6 months. The existence of a terminal disease,
166	166
167	167
168	168
169	169
170	170
171	171	SB0009 - 4 - LRB104 06297 BDA 16332 b
172	172
173	173
174	174	SB0009- 5 -LRB104 06297 BDA 16332 b SB0009 - 5 - LRB104 06297 BDA 16332 b
175	175	SB0009 - 5 - LRB104 06297 BDA 16332 b
176	176	1 as determined after in-person examination by the patient's
177	177	2 physician and concurrence by another physician, shall be
178	178	3 documented in writing in the patient's medical record. A
179	179	4 diagnosis of a major depressive disorder, as defined in the
180	180	5 current edition of the Diagnostic and Statistical Manual of
181	181	6 Mental Disorders, alone does not qualify as a terminal
182	182	7 disease.
183	183	8 Section 10. Informed consent.
184	184	9 (a) Nothing in this Act may be construed to limit the
185	185	10 amount of information provided to a patient to ensure the
186	186	11 patient can make a fully informed health care decision.
187	187	12 (b) An attending physician must provide sufficient
188	188	13 information to a patient regarding all appropriate end-of-life
189	189	14 care options, including comfort care, hospice care, palliative
190	190	15 care, and pain control, as well as the foreseeable risks and
191	191	16 benefits of each, so that the patient can make a voluntary and
192	192	17 affirmative decision regarding the patient's end-of-life care.
193	193	18 (c) If a patient makes a request for the patient's medical
194	194	19 records to be transmitted to an alternative physician, the
195	195	20 patient's medical records shall be transmitted without undue
196	196	21 delay.
197	197	22 Section 15. Standard of care. Nothing contained in this
198	198	23 Act shall be interpreted to lower the applicable standard of
199	199	24 care for the health care professionals participating under
200	200
201	201
202	202
203	203
204	204
205	205	SB0009 - 5 - LRB104 06297 BDA 16332 b
206	206
207	207
208	208	SB0009- 6 -LRB104 06297 BDA 16332 b SB0009 - 6 - LRB104 06297 BDA 16332 b
209	209	SB0009 - 6 - LRB104 06297 BDA 16332 b
210	210	1 this Act.
211	211	2 Section 20. Qualification.
212	212	3 (a) A qualified patient with a terminal disease may
213	213	4 request a prescription for medication under this Act in the
214	214	5 following manner:
215	215	6 (1) The qualified patient may orally request a
216	216	7 prescription for medication under this Act from the
217	217	8 patient's attending physician.
218	218	9 (2) The oral request from the qualified patient shall
219	219	10 be documented by the attending physician.
220	220	11 (3) The qualified patient shall provide a written
221	221	12 request in accordance with this Act to the patient's
222	222	13 attending physician after making the initial oral request.
223	223	14 (4) The qualified patient shall repeat the oral
224	224	15 request to the patient's attending physician no less than
225	225	16 5 days after making the initial oral request.
226	226	17 (b) The attending and consulting physicians of a qualified
227	227	18 patient shall have met all the requirements of Sections 30 and
228	228	19 35.
229	229	20 (c) Notwithstanding subsection (a), if the individual's
230	230	21 attending physician has medically determined that the
231	231	22 individual will, within reasonable medical judgment, die
232	232	23 within 5 days after making the initial oral request under this
233	233	24 Section, the individual may satisfy the requirements of this
234	234	25 Section by providing a written request and reiterating the
235	235
236	236
237	237
238	238
239	239
240	240	SB0009 - 6 - LRB104 06297 BDA 16332 b
241	241
242	242
243	243	SB0009- 7 -LRB104 06297 BDA 16332 b SB0009 - 7 - LRB104 06297 BDA 16332 b
244	244	SB0009 - 7 - LRB104 06297 BDA 16332 b
245	245	1 oral request to the attending physician at any time after
246	246	2 making the initial oral request.
247	247	3 (d) At the time the patient makes the second oral request,
248	248	4 the attending physician shall offer the patient an opportunity
249	249	5 to rescind the request.
250	250	6 (e) Oral and written requests for aid in dying may be made
251	251	7 only by the patient and shall not be made by the patient's
252	252	8 surrogate decision-maker, health care proxy, health care
253	253	9 agent, attorney-in-fact for health care, nor via advance
254	254	10 health care directive.
255	255	11 (f) If a requesting patient decides to transfer care to an
256	256	12 alternative physician, the records custodian shall, upon
257	257	13 written request, transmit, without undue delay, the patient's
258	258	14 medical records, including written documentation of the dates
259	259	15 of the patient's requests concerning aid in dying.
260	260	16 (g) A transfer of care or medical records does not toll or
261	261	17 restart any waiting period.
262	262	18 Section 25. Form of written request.
263	263	19 (a) A written request for medication under this Act shall
264	264	20 be in substantially the form below, signed and dated by the
265	265	21 requesting patient, and witnessed in the presence of the
266	266	22 patient by at least 2 witnesses who attest that to the best of
267	267	23 their knowledge and belief the patient has mental capacity, is
268	268	24 acting voluntarily, and is not being coerced or unduly
269	269	25 influenced to sign the request.
270	270
271	271
272	272
273	273
274	274
275	275	SB0009 - 7 - LRB104 06297 BDA 16332 b
276	276
277	277
278	278	SB0009- 8 -LRB104 06297 BDA 16332 b SB0009 - 8 - LRB104 06297 BDA 16332 b
279	279	SB0009 - 8 - LRB104 06297 BDA 16332 b
280	280	1 (b) One of the witnesses required under this Section must
281	281	2 be a person who is not:
282	282	3 (1) a relative of the patient by blood, marriage,
283	283	4 civil union, registered domestic partnership, or adoption;
284	284	5 (2) a person who, at the time the request is signed,
285	285	6 would be entitled to any portion of the estate of the
286	286	7 qualified patient upon death, under any will or by
287	287	8 operation of law; or
288	288	9 (3) an owner, operator, or employee of a health care
289	289	10 entity where the qualified patient is receiving medical
290	290	11 treatment or is a resident.
291	291	12 (c) The patient's attending physician at the time the
292	292	13 request is signed shall not be a witness.
293	293	14 (d) If a person uses an interpreter, the interpreter shall
294	294	15 not be a witness.
295	295	16 (e) The written request for medication under this Act
296	296	17 shall be substantially as follows:
297	297	18 "Request for Medication to End My Life in a Peaceful Manner
298	298	19 I, ............... (NAME OF PATIENT), am an adult of sound
299	299	20 mind, and a resident of Illinois. I have been diagnosed with
300	300	21 ............... (NAME OF CONDITION) and given a terminal
301	301	22 disease prognosis of 6 months or less to live by my attending
302	302	23 physician.
303	303	24 I affirm that my terminal disease diagnosis was given or
304	304
305	305
306	306
307	307
308	308
309	309	SB0009 - 8 - LRB104 06297 BDA 16332 b
310	310
311	311
312	312	SB0009- 9 -LRB104 06297 BDA 16332 b SB0009 - 9 - LRB104 06297 BDA 16332 b
313	313	SB0009 - 9 - LRB104 06297 BDA 16332 b
314	314	1 confirmed during at least one in-person visit to a health care
315	315	2 professional.
316	316	3 I have been fully informed of the feasible alternatives
317	317	4 and concurrent or additional treatment opportunities for my
318	318	5 terminal disease, including, but not limited to, comfort care,
319	319	6 palliative care, hospice care, or pain control, as well as the
320	320	7 potential risks and benefits of each. I have been offered,
321	321	8 have received, or have been offered and received resources or
322	322	9 referrals to pursue these alternatives and concurrent or
323	323	10 additional treatment opportunities for my terminal disease.
324	324	11 I have been fully informed of the nature of the medication
325	325	12 to be prescribed, including the risks and benefits, and I
326	326	13 understand that the likely outcome of self-administering the
327	327	14 medication is death.
328	328	15 I understand that I can rescind this request at any time,
329	329	16 that I am under no obligation to fill the prescription once
330	330	17 written, and that I have no duty to self-administer the
331	331	18 medication if I obtain it.
332	332	19 I request that my attending physician furnish a
333	333	20 prescription for medication that will end my life if I choose
334	334	21 to self-administer it, and I authorize my attending physician
335	335	22 to transmit the prescription to a pharmacist to dispense the
336	336	23 medication at a time of my choosing.
337	337	24 I make this request voluntarily, free from coercion or
338	338	25 undue influence.
339	339	26 Dated: ................
340	340
341	341
342	342
343	343
344	344
345	345	SB0009 - 9 - LRB104 06297 BDA 16332 b
346	346
347	347
348	348	SB0009- 10 -LRB104 06297 BDA 16332 b SB0009 - 10 - LRB104 06297 BDA 16332 b
349	349	SB0009 - 10 - LRB104 06297 BDA 16332 b
350	350	1 Signed..............................................
351	351	2 (patient)
352	352	3 Dated: ................
353	353	4 Signed...........................................
354	354	5 (witness #1)
355	355	6 Dated: ................
356	356	7 Signed..........................................
357	357	8 (witness #2)"
358	358	9 (f) The interpreter attachment for a written request for
359	359	10 medication under this Act shall be substantially as follows:
360	360	11 "Request for Medication to End My Life in a Peaceful Manner
361	361	12 Interpreter Attachment
362	362	13 I, ............... (NAME OF INTERPRETER), am fluent in
363	363	14 English and ............... (LANGUAGE OF PATIENT, INCLUDING
364	364	15 SIGN LANGUAGE).
365	365	16 On ....... (DATE) at approximately ....... (TIME), I read
366	366	17 the "Request for Medication to End My Life in a Peaceful
367	367	18 Manner" form to ............... (NAME OF PATIENT) in
368	368	19 ............... (LANGUAGE OF PATIENT, INCLUDING SIGN
369	369	20 LANGUAGE).
370	370	21 ............... (NAME OF PATIENT) affirmed to me that they
371	371	22 understand the content of this form, that they desire to sign
372	372	23 this form under their own power and volition, and that they
373	373
374	374
375	375
376	376
377	377
378	378	SB0009 - 10 - LRB104 06297 BDA 16332 b
379	379
380	380
381	381	SB0009- 11 -LRB104 06297 BDA 16332 b SB0009 - 11 - LRB104 06297 BDA 16332 b
382	382	SB0009 - 11 - LRB104 06297 BDA 16332 b
383	383	1 requested to sign the form after consultations with an
384	384	2 attending physician and a consulting physician.
385	385	3 Under penalty of perjury, I declare that I am fluent in
386	386	4 English and ............... (LANGUAGE OF PATIENT, INCLUDING
387	387	5 SIGN LANGUAGE) and that the contents of this form, to the best
388	388	6 of my knowledge, are true and correct. Executed at
389	389	7 .................................. (NAME OF CITY, COUNTY, AND
390	390	8 STATE) on ....... (DATE).
391	391	9 Interpreter's signature: ....................................
392	392	10 Interpreter's printed name: .................................
393	393	11 Interpreter's address: ......................................".
394	394	12 Section 30. Attending physician responsibilities.
395	395	13 (a) Following the request of a patient for aid in dying,
396	396	14 the attending physician shall conduct an evaluation of the
397	397	15 patient and:
398	398	16 (1) determine whether the patient has a terminal
399	399	17 disease or has been diagnosed as having a terminal
400	400	18 disease;
401	401	19 (2) determine whether a patient has mental capacity;
402	402	20 (3) confirm that the patient's request does not arise
403	403	21 from coercion or undue influence;
404	404	22 (4) inform the patient of:
405	405	23 (A) the diagnosis;
406	406	24 (B) the prognosis;
407	407	25 (C) the potential risks, benefits, and probable
408	408
409	409
410	410
411	411
412	412
413	413	SB0009 - 11 - LRB104 06297 BDA 16332 b
414	414
415	415
416	416	SB0009- 12 -LRB104 06297 BDA 16332 b SB0009 - 12 - LRB104 06297 BDA 16332 b
417	417	SB0009 - 12 - LRB104 06297 BDA 16332 b
418	418	1 result of self-administering the prescribed medication
419	419	2 to bring about a peaceful death;
420	420	3 (D) the potential benefits and risks of feasible
421	421	4 alternatives, including, but not limited to,
422	422	5 concurrent or additional treatment options for the
423	423	6 patient's terminal disease, comfort care, palliative
424	424	7 care, hospice care, and pain control; and
425	425	8 (E) the patient's right to rescind the request for
426	426	9 medication pursuant to this Act at any time;
427	427	10 (5) inform the patient that there is no obligation to
428	428	11 fill the prescription nor an obligation to self-administer
429	429	12 the medication, if it is obtained;
430	430	13 (6) provide the patient with a referral for comfort
431	431	14 care, palliative care, hospice care, pain control, or
432	432	15 other end-of-life treatment options as requested by the
433	433	16 patient and as clinically indicated;
434	434	17 (7) refer the patient to a consulting physician for
435	435	18 medical confirmation that the patient requesting
436	436	19 medication pursuant to this Act:
437	437	20 (A) has a terminal disease with a prognosis of 6
438	438	21 months or less to live; and
439	439	22 (B) has mental capacity.
440	440	23 (8) include the consulting physician's written
441	441	24 determination in the patient's medical record;
442	442	25 (9) refer the patient to a licensed mental health
443	443	26 professional in accordance with Section 40 if the
444	444
445	445
446	446
447	447
448	448
449	449	SB0009 - 12 - LRB104 06297 BDA 16332 b
450	450
451	451
452	452	SB0009- 13 -LRB104 06297 BDA 16332 b SB0009 - 13 - LRB104 06297 BDA 16332 b
453	453	SB0009 - 13 - LRB104 06297 BDA 16332 b
454	454	1 attending physician observes signs that the individual may
455	455	2 not be capable of making an informed decision;
456	456	3 (10) include the licensed mental health professional's
457	457	4 written determination in the patient's medical record, if
458	458	5 such determination was requested;
459	459	6 (11) inform the patient of the benefits of notifying
460	460	7 the next of kin of the patient's decision to request
461	461	8 medication pursuant to this Act;
462	462	9 (12) fulfill the medical record documentation
463	463	10 requirements;
464	464	11 (13) ensure that all steps are carried out in
465	465	12 accordance with this Act before providing a prescription
466	466	13 to a qualified patient for medication pursuant to this Act
467	467	14 including:
468	468	15 (A) confirming that the patient has made an
469	469	16 informed decision to obtain a prescription for
470	470	17 medication;
471	471	18 (B) offering the patient an opportunity to rescind
472	472	19 the request for medication; and
473	473	20 (C) providing information to the patient on:
474	474	21 (I) the recommended procedure for
475	475	22 self-administering the medication to be
476	476	23 prescribed;
477	477	24 (II) the safekeeping and proper disposal of
478	478	25 unused medication in accordance with State and
479	479	26 federal law;
480	480
481	481
482	482
483	483
484	484
485	485	SB0009 - 13 - LRB104 06297 BDA 16332 b
486	486
487	487
488	488	SB0009- 14 -LRB104 06297 BDA 16332 b SB0009 - 14 - LRB104 06297 BDA 16332 b
489	489	SB0009 - 14 - LRB104 06297 BDA 16332 b
490	490	1 (III) the importance of having another person
491	491	2 present when the patient self-administers the
492	492	3 medication to be prescribed; and
493	493	4 (IV) not taking the aid-in-dying medication in
494	494	5 a public place.
495	495	6 (D) not taking the aid-in-dying medication in a
496	496	7 public place;
497	497	8 (14) deliver, in accordance with State and federal
498	498	9 law, the prescription personally, by mail, or through an
499	499	10 authorized electronic transmission to a licensed
500	500	11 pharmacist who will dispense the medication, including any
501	501	12 ancillary medications, to the qualified patient, or to a
502	502	13 person expressly designated by the qualified patient in
503	503	14 person or with a signature required on delivery, by mail
504	504	15 service, or by messenger service;
505	505	16 (15) if authorized by the Drug Enforcement
506	506	17 Administration, dispense the prescribed medication,
507	507	18 including any ancillary medications, to the qualified
508	508	19 patient or a person designated by the qualified patient;
509	509	20 and
510	510	21 (16) include, in the qualified patient's medical
511	511	22 record, the patient's diagnosis and prognosis,
512	512	23 determination of mental capacity, the date of each oral
513	513	24 request, a copy of the written request, a notation that
514	514	25 the requirements under this Section have been completed,
515	515	26 and an identification of the medication and ancillary
516	516
517	517
518	518
519	519
520	520
521	521	SB0009 - 14 - LRB104 06297 BDA 16332 b
522	522
523	523
524	524	SB0009- 15 -LRB104 06297 BDA 16332 b SB0009 - 15 - LRB104 06297 BDA 16332 b
525	525	SB0009 - 15 - LRB104 06297 BDA 16332 b
526	526	1 medications prescribed to the qualified patient pursuant
527	527	2 to this Act.
528	528	3 (b) Notwithstanding any other provision of law, the
529	529	4 attending physician may sign the patient's death certificate.
530	530	5 Section 35. Consulting physician responsibilities. A
531	531	6 consulting physician shall:
532	532	7 (1) conduct an evaluation of the patient and review
533	533	8 the patient's relevant medical records, including the
534	534	9 evaluation pursuant to Section 40, if such evaluation was
535	535	10 necessary;
536	536	11 (2) confirm in writing to the attending physician that
537	537	12 the patient:
538	538	13 (A) has requested a prescription for aid-in-dying
539	539	14 medication;
540	540	15 (B) has a documented terminal disease;
541	541	16 (C) has mental capacity or has provided
542	542	17 documentation that the consulting health care
543	543	18 professional has referred the individual for further
544	544	19 evaluation in accordance with Section 40; and
545	545	20 (D) is acting voluntarily, free from coercion or
546	546	21 undue influence.
547	547	22 Section 40. Referral for determination that the requesting
548	548	23 patient has mental capacity.
549	549	24 (a) If either the attending physician or the consulting
550	550
551	551
552	552
553	553
554	554
555	555	SB0009 - 15 - LRB104 06297 BDA 16332 b
556	556
557	557
558	558	SB0009- 16 -LRB104 06297 BDA 16332 b SB0009 - 16 - LRB104 06297 BDA 16332 b
559	559	SB0009 - 16 - LRB104 06297 BDA 16332 b
560	560	1 physician has doubts whether the individual has mental
561	561	2 capacity and if either one is unable to confirm that the
562	562	3 individual is capable of making an informed decision, the
563	563	4 attending physician or consulting physician shall refer the
564	564	5 patient to a licensed mental health professional for
565	565	6 determination regarding mental capability.
566	566	7 (b) The licensed mental health professional shall
567	567	8 additionally determine whether the patient is suffering from a
568	568	9 psychiatric or psychological disorder causing impaired
569	569	10 judgment.
570	570	11 (c) The licensed mental health professional who evaluates
571	571	12 the patient under this Section shall submit to the requesting
572	572	13 attending or consulting physician a written determination of
573	573	14 whether the patient has mental capacity.
574	574	15 (d) If the licensed mental health professional determines
575	575	16 that the patient does not have mental capacity, or is
576	576	17 suffering from a psychiatric or psychological disorder causing
577	577	18 impaired judgment, the patient shall not be deemed a qualified
578	578	19 patient and the attending physician shall not prescribe
579	579	20 medication to the patient under this Act.
580	580	21 Section 45. Residency requirement.
581	581	22 (a) Only requests made by Illinois residents may be
582	582	23 granted under this Act.
583	583	24 (b) A patient is able to establish residency through any
584	584	25 one or more of the following means:
585	585
586	586
587	587
588	588
589	589
590	590	SB0009 - 16 - LRB104 06297 BDA 16332 b
591	591
592	592
593	593	SB0009- 17 -LRB104 06297 BDA 16332 b SB0009 - 17 - LRB104 06297 BDA 16332 b
594	594	SB0009 - 17 - LRB104 06297 BDA 16332 b
595	595	1 (1) possession of a driver's license or other
596	596	2 identification issued by the Secretary of State or State
597	597	3 of Illinois;
598	598	4 (2) registration to vote in Illinois;
599	599	5 (3) evidence that the person owns, rents, or leases
600	600	6 property in Illinois;
601	601	7 (4) the location of any dwelling occupied by the
602	602	8 person;
603	603	9 (5) the place where any motor vehicle owned by the
604	604	10 person is registered;
605	605	11 (6) the residence address, not a post office box,
606	606	12 shown on an income tax return filed for the year preceding
607	607	13 the year in which the person initially makes an oral
608	608	14 request under this Act;
609	609	15 (7) the residence address, not a post office box, at
610	610	16 which the person's mail is received;
611	611	17 (8) the residence address, not a post office box,
612	612	18 shown on any unexpired resident hunting or fishing or
613	613	19 other licenses held by the person;
614	614	20 (9) the residence address, not a post office box,
615	615	21 shown on any driver's license held by the person;
616	616	22 (10) the receipt of any public benefit conditioned
617	617	23 upon residency; or
618	618	24 (11) any other objective facts tending to indicate a
619	619	25 person's place of residence is in Illinois.
620	620
621	621
622	622
623	623
624	624
625	625	SB0009 - 17 - LRB104 06297 BDA 16332 b
626	626
627	627
628	628	SB0009- 18 -LRB104 06297 BDA 16332 b SB0009 - 18 - LRB104 06297 BDA 16332 b
629	629	SB0009 - 18 - LRB104 06297 BDA 16332 b
630	630	1 Section 50. Safe disposal of unused medications. A person
631	631	2 who has custody or control of medication prescribed pursuant
632	632	3 to this Act after the qualified patient's death shall dispose
633	633	4 of the medication by delivering it to the nearest qualified
634	634	5 facility that properly disposes of controlled substances or,
635	635	6 if none is available, by lawful means in accordance with
636	636	7 applicable State and federal guidelines.
637	637	8 Section 55. No duty to provide aid in dying.
638	638	9 (a) A health care professional shall not be under any
639	639	10 duty, by law or contract, to participate in the provision of
640	640	11 aid-in-dying care to a patient as set forth in this Act.
641	641	12 (b) A health care professional shall not be subject to
642	642	13 civil or criminal liability for participating or refusing to
643	643	14 participate in the provision of aid-in-dying care to a patient
644	644	15 in good faith compliance with this Act.
645	645	16 (c) A health care entity or licensing board shall not
646	646	17 subject a health care professional to censure, discipline,
647	647	18 suspension, loss of license, loss of privileges, loss of
648	648	19 membership, or other penalty for participating or refusing to
649	649	20 participate in accordance with this Act.
650	650	21 (d) A health care professional may choose not to engage in
651	651	22 aid-in-dying care.
652	652	23 (e) Only willing health care professionals shall provide
653	653	24 aid-in-dying care in accordance with this Act. If a health
654	654	25 care professional is unable or unwilling to carry out a
655	655
656	656
657	657
658	658
659	659
660	660	SB0009 - 18 - LRB104 06297 BDA 16332 b
661	661
662	662
663	663	SB0009- 19 -LRB104 06297 BDA 16332 b SB0009 - 19 - LRB104 06297 BDA 16332 b
664	664	SB0009 - 19 - LRB104 06297 BDA 16332 b
665	665	1 patient's request under this Act, and the patient transfers
666	666	2 the patient's care to a new health care professional, the
667	667	3 prior health care professional shall transmit, upon request, a
668	668	4 copy of the patient's relevant medical records to the new
669	669	5 health care professional without undue delay.
670	670	6 (f) A health care professional shall not engage in false,
671	671	7 misleading, or deceptive practices relating to a willingness
672	672	8 to qualify a patient or provide aid-in-dying care.
673	673	9 Intentionally misleading a patient constitutes coercion.
674	674	10 (g) The provisions of the Health Care Right of Conscience
675	675	11 Act apply to this Act and are incorporated by reference.
676	676	12 Section 60. Health care entity permissible prohibitions
677	677	13 and duties.
678	678	14 (a) A health care entity may prohibit health care
679	679	15 professionals from practicing aid-in-dying care while
680	680	16 performing duties for the entity. A prohibiting entity must
681	681	17 provide advance notice in writing to health care professionals
682	682	18 and staff at the time of hiring, contracting with, or
683	683	19 privileging and on a yearly basis thereafter.
684	684	20 (b) If a patient wishes to transfer care to another health
685	685	21 care entity, the prohibiting entity shall coordinate a timely
686	686	22 transfer of care, including transmitting, without undue delay,
687	687	23 the patient's medical records that include notation of the
688	688	24 date the patient first made a request concerning aid-in-dying
689	689	25 care.
690	690
691	691
692	692
693	693
694	694
695	695	SB0009 - 19 - LRB104 06297 BDA 16332 b
696	696
697	697
698	698	SB0009- 20 -LRB104 06297 BDA 16332 b SB0009 - 20 - LRB104 06297 BDA 16332 b
699	699	SB0009 - 20 - LRB104 06297 BDA 16332 b
700	700	1 (c) No health care entity shall prohibit a health care
701	701	2 professional from:
702	702	3 (1) providing information to a patient regarding the
703	703	4 patient's health status, including, but not limited to,
704	704	5 diagnosis, prognosis, recommended treatment and treatment
705	705	6 alternatives, and the risks and benefits of each;
706	706	7 (2) providing information regarding health care
707	707	8 services available pursuant to this Act, information about
708	708	9 relevant community resources, and how to access those
709	709	10 resources for obtaining care of the patient's choice;
710	710	11 (3) practicing aid-in-dying care outside the scope of
711	711	12 the health care professional's employment or contract with
712	712	13 the prohibiting entity and off the premises of the
713	713	14 prohibiting entity; or
714	714	15 (4) being present, if outside the scope of the health
715	715	16 care professional's employment or contractual duties, when
716	716	17 a qualified patient self-administers medication prescribed
717	717	18 pursuant to this Act or at the time of death, if requested
718	718	19 by the qualified patient or their representative.
719	719	20 (d) A health care entity shall not engage in false,
720	720	21 misleading, or deceptive practices relating to its policy
721	721	22 around end-of-life care services, including whether it has a
722	722	23 policy that prohibits affiliated health care professionals
723	723	24 from practicing aid-in-dying care; or intentionally denying a
724	724	25 patient access to medication pursuant to this Act by
725	725	26 intentionally failing to transfer a patient and the patient's
726	726
727	727
728	728
729	729
730	730
731	731	SB0009 - 20 - LRB104 06297 BDA 16332 b
732	732
733	733
734	734	SB0009- 21 -LRB104 06297 BDA 16332 b SB0009 - 21 - LRB104 06297 BDA 16332 b
735	735	SB0009 - 21 - LRB104 06297 BDA 16332 b
736	736	1 medical records to another health care professional in a
737	737	2 timely manner. Intentionally misleading a patient or deploying
738	738	3 misinformation to obstruct access to services pursuant to this
739	739	4 Act constitutes coercion or undue influence.
740	740	5 (e) The provisions of the Health Care Right of Conscience
741	741	6 Act apply to this Act and are incorporated by reference.
742	742	7 (f) If any part of this Section is found to be in conflict
743	743	8 with federal requirements which are a prescribed condition to
744	744	9 receipt of federal funds, the conflicting part of this Section
745	745	10 is inoperative solely to the extent of the conflict with
746	746	11 respect to the entity directly affected, and such finding or
747	747	12 determination shall not affect the operation of the remainder
748	748	13 of the Section or this Act.
749	749	14 Section 65. Immunities for actions in good faith;
750	750	15 prohibition against reprisals.
751	751	16 (a) A health care professional or health care entity shall
752	752	17 not be subject to civil or criminal liability, licensing
753	753	18 sanctions, or other professional disciplinary action for
754	754	19 actions taken in good faith compliance with this Act.
755	755	20 (b) If a health care professional or health care entity is
756	756	21 unable or unwilling to carry out an individual's request for
757	757	22 aid in dying, the professional or entity shall, at a minimum:
758	758	23 (1) inform the individual of the professional's or
759	759	24 entity's inability or unwillingness;
760	760	25 (2) refer the individual either to a health care
761	761
762	762
763	763
764	764
765	765
766	766	SB0009 - 21 - LRB104 06297 BDA 16332 b
767	767
768	768
769	769	SB0009- 22 -LRB104 06297 BDA 16332 b SB0009 - 22 - LRB104 06297 BDA 16332 b
770	770	SB0009 - 22 - LRB104 06297 BDA 16332 b
771	771	1 professional who is able and willing to evaluate and
772	772	2 qualify the individual or to another individual or entity
773	773	3 to assist the requesting individual in seeking aid in
774	774	4 dying, in accordance with the Health Care Right of
775	775	5 Conscience Act; and
776	776	6 (3) note, in the medical record, the individual's date
777	777	7 of request and health care professional's notice to the
778	778	8 individual of the health care professional's unwillingness
779	779	9 or inability to carry out the individual's request.
780	780	10 (c) A health care entity or licensing board shall not
781	781	11 subject a health care professional to censure, discipline,
782	782	12 suspension, loss of license, loss of privileges, loss of
783	783	13 membership, or other penalty for engaging in good faith
784	784	14 compliance with this Act.
785	785	15 (d) A health care professional, health care entity, or
786	786	16 licensing board shall not subject a health care professional
787	787	17 to discharge, demotion, censure, discipline, suspension, loss
788	788	18 of license, loss of privileges, loss of membership,
789	789	19 discrimination, or any other penalty for providing
790	790	20 aid-in-dying care in accordance with the standard of care and
791	791	21 in good faith under this Act when:
792	792	22 (1) engaged in the outside practice of medicine and
793	793	23 off of the objecting health care entity's premises; or
794	794	24 (2) providing scientific and accurate information
795	795	25 about aid-in-dying care to a patient when discussing
796	796	26 end-of-life care options.
797	797
798	798
799	799
800	800
801	801
802	802	SB0009 - 22 - LRB104 06297 BDA 16332 b
803	803
804	804
805	805	SB0009- 23 -LRB104 06297 BDA 16332 b SB0009 - 23 - LRB104 06297 BDA 16332 b
806	806	SB0009 - 23 - LRB104 06297 BDA 16332 b
807	807	1 (e) A physician is not subject to civil or criminal
808	808	2 liability or professional discipline if, at the request of the
809	809	3 qualified patient, the physician is present outside the scope
810	810	4 of the physician's employment contract and off the entity's
811	811	5 premises, when the qualified patient self-administers
812	812	6 medication pursuant to this Act, or at the time of death.
813	813	7 (f) A physician who is present at self-administration may,
814	814	8 without civil or criminal liability, assist the qualified
815	815	9 patient by preparing the medication prescribed pursuant to
816	816	10 this Act.
817	817	11 (g) A request by a patient for aid in dying does not alone
818	818	12 constitute grounds for neglect or elder abuse for any purpose
819	819	13 of law, nor shall it be the sole basis for appointment of a
820	820	14 guardian.
821	821	15 (h) This Section does not limit civil liability for
822	822	16 intentional misconduct.
823	823	17 Section 70. Reporting requirements.
824	824	18 (a) Within 45 days after the effective date of this Act,
825	825	19 the Department shall create and post to its website an
826	826	20 Attending Physician Checklist Form and Attending Physician
827	827	21 Follow-Up Form to facilitate collection of the information
828	828	22 described in this Section. Failure to create or post the
829	829	23 Attending Physician Checklist Form, the Attending Physician
830	830	24 Follow-Up Form, or both shall not suspend the effective date
831	831	25 of this Act.
832	832
833	833
834	834
835	835
836	836
837	837	SB0009 - 23 - LRB104 06297 BDA 16332 b
838	838
839	839
840	840	SB0009- 24 -LRB104 06297 BDA 16332 b SB0009 - 24 - LRB104 06297 BDA 16332 b
841	841	SB0009 - 24 - LRB104 06297 BDA 16332 b
842	842	1 (b) Within 30 calendar days of providing a prescription
843	843	2 for medication pursuant to this Act, the attending physician
844	844	3 shall submit to the Department an Attending Physician
845	845	4 Checklist Form with the following information:
846	846	5 (1) the qualifying patient's name and date of birth;
847	847	6 (2) the qualifying patient's terminal diagnosis and
848	848	7 prognosis;
849	849	8 (3) notice that the requirements under this Act were
850	850	9 completed; and
851	851	10 (4) notice that medication has been prescribed
852	852	11 pursuant to this Act.
853	853	12 (c) Within 60 calendar days of notification of a qualified
854	854	13 patient's death from self-administration of medication
855	855	14 prescribed pursuant to this Act, the attending physician shall
856	856	15 submit to the Department, an Attending Physician Follow-Up
857	857	16 Form with the following information:
858	858	17 (1) the qualified patient's name and date of birth;
859	859	18 (2) the date of the qualified patient's death; and
860	860	19 (3) a notation of whether the qualified patient was
861	861	20 enrolled in hospice services at the time of the qualified
862	862	21 patient's death.
863	863	22 (d) The Department shall collect and annually review the
864	864	23 forms filed pursuant to Section to ensure compliance. If a
865	865	24 physician required to report information to the Department
866	866	25 under this Act provides an inadequate or incomplete report,
867	867	26 the Department shall contact the physician to request an
868	868
869	869
870	870
871	871
872	872
873	873	SB0009 - 24 - LRB104 06297 BDA 16332 b
874	874
875	875
876	876	SB0009- 25 -LRB104 06297 BDA 16332 b SB0009 - 25 - LRB104 06297 BDA 16332 b
877	877	SB0009 - 25 - LRB104 06297 BDA 16332 b
878	878	1 adequate or complete report. The information collected shall
879	879	2 be confidential and shall be collected in a manner that
880	880	3 protects the privacy of the patient, the patient's family, and
881	881	4 any health care professional involved with the patient under
882	882	5 the provisions of this Act. The information shall be
883	883	6 privileged and strictly confidential, and shall not be
884	884	7 disclosed, discoverable, or compelled to be produced in any
885	885	8 civil, criminal, administrative, or other proceeding.
886	886	9 (e) One year after the effective date of this Act, and each
887	887	10 year thereafter, the Department shall create and post on its
888	888	11 website a public statistical report of nonidentifying
889	889	12 information. The report shall be limited to:
890	890	13 (1) the number of prescriptions for medication written
891	891	14 pursuant to this Act;
892	892	15 (2) the number of physicians who wrote prescriptions
893	893	16 for medication pursuant to this Act;
894	894	17 (3) the number of qualified patients who died
895	895	18 following self-administration of medication prescribed and
896	896	19 dispensed pursuant to this Act; and
897	897	20 (4) the number of people who died due to using an
898	898	21 aid-in-dying drug, with demographic percentages organized
899	899	22 by the following characteristics:
900	900	23 (A) age at death;
901	901	24 (B) education level;
902	902	25 (C) race;
903	903	26 (D) gender;
904	904
905	905
906	906
907	907
908	908
909	909	SB0009 - 25 - LRB104 06297 BDA 16332 b
910	910
911	911
912	912	SB0009- 26 -LRB104 06297 BDA 16332 b SB0009 - 26 - LRB104 06297 BDA 16332 b
913	913	SB0009 - 26 - LRB104 06297 BDA 16332 b
914	914	1 (E) type of insurance, including whether the
915	915	2 patient had insurance;
916	916	3 (F) underlying illness; and
917	917	4 (G) enrollment in hospice.
918	918	5 (f) Except as otherwise required by law, the information
919	919	6 collected by the Department is not a public record and is not
920	920	7 available for public inspection.
921	921	8 (g) Willful failure or refusal to timely submit records
922	922	9 required under this Act may result in disciplinary action.
923	923	10 Section 75. Effect on construction of wills, contracts,
924	924	11 and statutes.
925	925	12 (a) No provision in a contract, will, or other agreement,
926	926	13 whether written or oral, that would determine whether a
927	927	14 patient may make or rescind a request pursuant to this Act is
928	928	15 valid.
929	929	16 (b) No obligation owing under any contract that is in
930	930	17 effect on the effective date of this Act shall be conditioned
931	931	18 or affected by a patient's act of making or rescinding a
932	932	19 request pursuant to this Act.
933	933	20 (c) It is unlawful for an insurer to deny or alter health
934	934	21 care benefits otherwise available to a patient with a terminal
935	935	22 disease based on the availability of aid-in-dying care or
936	936	23 otherwise attempt to coerce a patient with a terminal disease
937	937	24 to make a request for aid-in-dying medication.
938	938	25 (d) Nothing in this Act prevents an insurer from
939	939
940	940
941	941
942	942
943	943
944	944	SB0009 - 26 - LRB104 06297 BDA 16332 b
945	945
946	946
947	947	SB0009- 27 -LRB104 06297 BDA 16332 b SB0009 - 27 - LRB104 06297 BDA 16332 b
948	948	SB0009 - 27 - LRB104 06297 BDA 16332 b
949	949	1 exercising any right to void a policy based on a material
950	950	2 misrepresentation, as provided under Section 154 of the
951	951	3 Illinois Insurance Code, in an application for insurance.
952	952	4 Section 80. Insurance or annuity policies.
953	953	5 (a) The sale, procurement, or issuance of a life, health,
954	954	6 or accident insurance policy, annuity policy, or the rate
955	955	7 charged for a policy shall not be conditioned upon or affected
956	956	8 by a patient's act of making or rescinding a request for
957	957	9 medication pursuant to this Act.
958	958	10 (b) A qualified patient's act of self-administering
959	959	11 medication pursuant to this Act does not invalidate any part
960	960	12 of a life, health, or accident insurance, or annuity policy.
961	961	13 (c) An insurance plan, including medical assistance under
962	962	14 Article V of the Illinois Public Aid Code, shall not deny or
963	963	15 alter benefits to a patient with a terminal disease who is a
964	964	16 covered beneficiary of a health insurance plan, based on the
965	965	17 availability of aid-in-dying care, their request for
966	966	18 medication pursuant to this Act, or the absence of a request
967	967	19 for medication pursuant to this Act. Failure to meet this
968	968	20 requirement shall constitute a violation of the Illinois
969	969	21 Insurance Code.
970	970	22 Section 85. Death certificate.
971	971	23 (a) Unless otherwise prohibited by law, the attending
972	972	24 physician may sign the death certificate of a qualified
973	973
974	974
975	975
976	976
977	977
978	978	SB0009 - 27 - LRB104 06297 BDA 16332 b
979	979
980	980
981	981	SB0009- 28 -LRB104 06297 BDA 16332 b SB0009 - 28 - LRB104 06297 BDA 16332 b
982	982	SB0009 - 28 - LRB104 06297 BDA 16332 b
983	983	1 patient who obtained and self-administered a prescription for
984	984	2 medication pursuant to this Act.
985	985	3 (b) When a death has occurred in accordance with this Act,
986	986	4 the death shall be attributed to the underlying terminal
987	987	5 disease.
988	988	6 (1) Death following self-administering medication
989	989	7 under this Act does not alone constitute grounds for
990	990	8 postmortem inquiry.
991	991	9 (2) Death in accordance with this Act shall not be
992	992	10 designated a suicide or homicide.
993	993	11 (c) A qualified patient's act of self-administering
994	994	12 medication prescribed pursuant to this Act shall not be
995	995	13 indicated on the death certificate.
996	996	14 Section 90. Liabilities and penalties.
997	997	15 (a) Nothing in this Act limits civil or criminal liability
998	998	16 arising from:
999	999	17 (1) Intentionally or knowingly altering or forging a
1000	1000	18 patient's request for medication pursuant to this Act or
1001	1001	19 concealing or destroying a rescission of a request for
1002	1002	20 medication pursuant to this Act.
1003	1003	21 (2) Intentionally or knowingly coercing or exerting
1004	1004	22 undue influence on a patient with a terminal disease to
1005	1005	23 request medication pursuant to this Act or to request or
1006	1006	24 use or not use medication pursuant to this Act.
1007	1007	25 (3) Intentional misconduct by a health care
1008	1008
1009	1009
1010	1010
1011	1011
1012	1012
1013	1013	SB0009 - 28 - LRB104 06297 BDA 16332 b
1014	1014
1015	1015
1016	1016	SB0009- 29 -LRB104 06297 BDA 16332 b SB0009 - 29 - LRB104 06297 BDA 16332 b
1017	1017	SB0009 - 29 - LRB104 06297 BDA 16332 b
1018	1018	1 professional or health care entity.
1019	1019	2 (b) The penalties specified in this Act do not preclude
1020	1020	3 criminal penalties applicable under other laws for conduct
1021	1021	4 inconsistent with this Act.
1022	1022	5 (c) As used in this Section, "intentionally" and
1023	1023	6 "knowingly" have the meanings provided in Sections 4-4 and 4-5
1024	1024	7 of the Criminal Code of 2012.
1025	1025	8 Section 95. Construction.
1026	1026	9 (a) Nothing in this Act authorizes a physician or any
1027	1027	10 other person, including the qualified patient, to end the
1028	1028	11 qualified patient's life by lethal injection, lethal infusion,
1029	1029	12 mercy killing, homicide, murder, manslaughter, euthanasia, or
1030	1030	13 any other criminal act.
1031	1031	14 (b) Actions taken in accordance with this Act do not, for
1032	1032	15 any purposes, constitute suicide, assisted suicide,
1033	1033	16 euthanasia, mercy killing, homicide, murder, manslaughter,
1034	1034	17 elder abuse or neglect, or any other civil or criminal
1035	1035	18 violation under the law.
1036	1036	19 Section 100. Severability. The provisions of this Act are
1037	1037	20 severable under Section 1.31 of the Statute on Statutes.
1038	1038
1039	1039
1040	1040
1041	1041
1042	1042
1043	1043	SB0009 - 29 - LRB104 06297 BDA 16332 b